In many accountable care organizations (ACOs), frontline physicians are under strong pressure to schedule Medicare annual wellness visits (AWVs) for every eligible patient. On paper, AWVs are framed as a cornerstone of value‑based care. In reality, for patients who already receive regular, well‑designed chronic care and follow‑up visits, a separate AWV can easily become cost‑ineffective. It adds encounters and expense without…

The days of pharmacy’s financial survival hinging almost entirely on dispensing volume are numbered. For forward-thinking pharmacies willing to embrace value-based care, this shift represents one of the biggest opportunities the profession has seen in decades, impacting both clinical services and financial sustainability. “My best answer is [value-based programs are] coming regardless,” said Kevin Day,…

Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance Capital, April was the biggest month for biotech IPO proceeds in more than five years. The biotech IPO window looks like it’s reopening. This past week closed with three…

The year 2025 wasn’t easy for most ACOs struggling with the sudden transition to data aggregation. In fact, it was a trial by fire. ACOs joined the modern era of quality reporting in 2025 with APP (APM Performance Pathway) Reporting, which spurred aggregation from multiple practice systems and patient matching across the ACO. This required…

In time, value-based care will come to hospices, and they must be ready, according to Kent Anderson, CEO of Ohio’s Hospice. In this environment, scale will be key, as will a need to better understand the needs and objectives of referral partners, Anderson told Hospice News. He also leads Metta Health, a revenue cycle management…